Education
About Us
Working with TipRanks
Follow Us
BioRegenx (BRGX)
OTHER OTC:BRGX
Total Valuation
BioRegenx has a market cap or net worth of $10.00M. The enterprise value is $15.66M.
Market Cap$10.00M
Enterprise Value$15.66M
Share Statistics
BioRegenx has 961,992,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding961,992,600
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
BioRegenx’s return on equity (ROE) is 6.82 and return on invested capital (ROIC) is 1873.53%.
Return on Equity (ROE)6.82
Return on Assets (ROA)-45.33
Return on Invested Capital (ROIC)1873.53%
Return on Capital Employed (ROCE)7.29
Revenue Per Employee468.00K
Profits Per Employee-4.46M
Employee Count5
Asset Turnover4.60
Inventory Turnover6.14
Valuation Ratios
The current PE Ratio of BioRegenx is ―. BioRegenx’s PEG ratio is -0.00043.
PE Ratio―
PS Ratio3.61
PB Ratio-2.50
Price to Fair Value-2.50
Price to FCF-16.47
Price to Operating Cash Flow-35.39
PEG Ratio-0.00043
Income Statement
In the last 12 months, BioRegenx had revenue of 2.34M and earned -23.05M in profits. Earnings per share was -0.02.
Revenue2.34M
Gross Profit1.66M
Operating Income-22.76M
Pretax Income-23.05M
Net Income-23.05M
EBITDA-22.76M
Earnings Per Share (EPS)-0.02
Cash Flow
In the last 12 months, operating cash flow was -380.11K and capital expenditures 18.79M, giving a free cash flow of 18.41M billion.
Operating Cash Flow-380.11K
Free Cash Flow18.41M
Free Cash Flow per Share0.02
Dividends & Yields
BioRegenx pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.64
52-Week Price Change25.00%
50-Day Moving Average0.01
200-Day Moving Average0.01
Relative Strength Index (RSI)45.32
Average Volume (3m)59.55K
Important Dates
BioRegenx upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
BioRegenx as a current ratio of 0.08, with Debt / Equity ratio of -61.82%
Current Ratio0.08
Quick Ratio0.05
Debt to Market Cap0.26
Net Debt to EBITDA-0.09
Interest Coverage Ratio-78.32
Taxes
In the past 12 months, BioRegenx has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
BioRegenx EV to EBITDA ratio is -0.46, with an EV/FCF ratio of -20.57.
EV to Sales4.51
EV to EBITDA-0.46
EV to Free Cash Flow-20.57
EV to Operating Cash Flow-32.58
Balance Sheet
BioRegenx has $46.95K in cash and marketable securities with $2.25M in debt, giving a net cash position of -$2.21M billion.
Cash & Marketable Securities$46.95K
Total Debt$2.25M
Net Cash-$2.21M
Net Cash Per Share>-$0.01
Tangible Book Value Per Share>-$0.01
Margins
Gross margin is 159.63%, with operating margin of -972.79%, and net profit margin of -985.21%.
Gross Margin159.63%
Operating Margin-972.79%
Pretax Margin-985.21%
Net Profit Margin-985.21%
EBITDA Margin-972.78%
EBIT Margin-972.79%
Analyst Forecast
The average price target for BioRegenx is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―